BW

CARD8 polyclonal Antibody | BS6022

(No reviews yet) Write a Review
SKU:
BW-BS6022
Availability:
Usually ships in 5 working days
NULL444.00 - NULL678.00

Description

CARD8 polyclonal Antibody | BS6022 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human,Mouse,Rat

Application: WB

Application Range: WB 1:500 - 1:2000

Background: The MAGUK family includes several mammalian proteins, such as postsynaptic proteins, GKAPs, the tight junction associated proteins (ZO-1-3), and the caspase-associated recruitment domain (CARD) proteins, all of which are related to the Drosophila tumor suppressor discs-large (dlg) gene product. CARD 8, also designated DACAR, NDPP1, TUCAN or CARDINAL, is a 431 amino acid protein that is expressed in the lung, ovary, testis, and placenta. It regulates cellular responses controlled by NF-˚ B activation and may play a key role in apoptosis and chronic inflammatory disorders. CARD 8 binds to caspase-1 and negatively regulates its activity.

Storage & Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: CARD8 polyclonal Antibody detects endogenous levels of CARD8 protein.

Molecular Weight: ~ 60 kDa

Note: For research use only, not for use in diagnostic procedure.

Alternative Names: Apoptotic protein NDPP 1; Apoptotic protein NDPP1; CARD 8; CARD inhibitor of NF kappa B activating ligand; CARD inhibitor of NF kappaB activating ligand; CARD inhibitor of NF kappaB activating ligands; CARD-inhibitor of NF-kappa-B-activating ligand; CARD8; CARD8; CARDINAL; Caspase recruitment domain containing protein 8; Caspase recruitment domain family member 8; Caspase recruitment domain protein 8; Caspase recruitment domain-containing protein 8; DACAR; DKFZp779L0366; KI

Immunogen: Recombinant full length Human CARD8.

Conjugate: Unconjugated

Modification: Unmodification

Purification & Purity: The Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE) .

Pathway: Nuclear Receptor Signaling,

View AllClose